FDA Inspection 1078252 — Desert Medical Advances
The FDA completed an inspection of Desert Medical Advances on Jan 18, 2019 in Palm Desert, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 18, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Palm Desert, CA (United States)
Additional details
Clinical BA/BE